CLARIVATE PLC

CLVT
About the company

Clarivate Plc provides information services in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

Country: JerseyPrice: $2.33Market Cap: $1.5B

Investment snapshot

18%positive consensus
Scored 1d ago

Positive

3

BUY / PASS

Neutral / negative

3 / 10

NEUTRAL / FAIL

Median fair value

$5.63

+141.4% vs price

Models with upside

4 / 17

Positive margin of safety

Strongest signal

CLVT undervalued: all 4 models price fair value above $2.33 (median $5.63)

Key risk

No clean pass — all 8 investors flag at least one growth criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedNEUTRALFAILPASSNEUTRALFAILFAILPASSNEUTRALPASSFAILFAILFAILFAIL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/A+56.9%N/AN/AN/AN/A+64.4%+59.3%N/AN/A+57.9%N/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-24

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-24

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Where It Passes

  • Valuation models100% pass✓ 4▾

    CLVT undervalued: all 4 models price fair value above $2.33 (median $5.63)

    Buffett fair value$5.40
    ✓Buffett+56.9% margin vs $2.33
    Munger fair value$6.54
    ✓Munger+64.4% margin vs $2.33
    Pabrai fair value$5.72
    ✓Pabrai+59.3% margin vs $2.33
    Ackman fair value$5.53
    ✓Ackman+57.9% margin vs $2.33
  • Cash Flow90% pass✓ 11✗ 1▾

    9 of 10 pass — Lynch objects

    Free Cash Flow Proxy$292.9M
    ✓BuffettPositive and growing
    FCF Positive and Growing$322.3M
    ✗LynchPositive and growing
    Operating Cash Flow$628.5M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=5.68%, ROA=-1.82%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)2.4x
    ✓Dreman< 8x
    P/E or FCF YieldFCF Yield=24.5%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive7/9 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap21.6%
    ✓Ackman>= 4%
    Price / FCF per Share4.1x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency8/9 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$322.3M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+21.62%; #270/4519 (top 6.0%)
    ✓OshaughnessyTop 10% of eligible cross-section

Where It Falls Short

  • Growth0% pass✓ 3✗ 10▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency0/9 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-2.7%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency3/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 65.5% -> 66.0%, operating margin -27.9% -> 2.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR14.4%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Efficiency0% pass✗ 11▾

    All 8 investors flag CLVT's efficiency

    Current Ratio0.88
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-7.0%
    ✗Buffett> 10%
    ROIC - WACC-17.0%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.87 -> 0.84
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.22x -> 0.22x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities0.88
    ✗Dreman> 1.5
    Return on Invested Capital-0.8%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-5.4%; FY2024: ROIC=-2.3%; FY2025: ROIC=0.6%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 0.6%)
    ✗SleepROIC > 12% in a majority of years
  • Profitability6% pass✓ 6✗ 29▾

    15 of 16 flag CLVT's profitability — Graham, Buffett, Lynch +12 more

    Positive EPS (10 years)0/10 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)0/10 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-18.4%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)2.9% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$292.9M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-8.6%
    ✗Lynch> 15%
    EBIT / Enterprise Value1.3%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=1.3%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-1.82%
    ✗PiotroskiROA > 0
    ROA Change YoY-5.54% -> -1.82% (delta: +3.72%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=5.68%, ROA=-1.82%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY66.0% -> 66.0%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-14.7%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-8.6%
    ✗Dreman> 12%
    Margin of SafetyP/B=0.3x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity-10.6% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency0/9 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-3.9%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-8.6%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-27.9% (2023) -> 2.9% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 65.5% -> 66.0%, operating margin -27.9% -> 2.9%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-25.92%; #4714/6340 (top 74.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+14.65%; #2451/3702 (top 66.2%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-8.56%; #3353/5226 (top 64.2%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.1002; #3484/5884 (top 59.2%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years0/9 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation23% pass✓ 11✗ 17▾

    10 of 13 flag CLVT's valuation — Graham, Lynch, Greenblatt +7 more

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio0.3x
    ✓Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value1.3%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=1.3%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)2.4x
    ✓Dreman< 8x
    Price / Book Value per Share0.3x
    ✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=19.6%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=24.5%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/B=0.3x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share4.1x
    ✓Ackman<= 25
    Price vs. Trailing Low136% of trailing low ($1.71)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-25.92%; #4714/6340 (top 74.4%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+3.0278; #457/6449 (top 7.1%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change-49.2%
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+1.5234; #1313/5247 (top 25.0%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+21.62%; #270/4519 (top 6.0%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+7.37%; #2001/6202 (top 32.3%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts23% pass✓ 3✗ 10▾

    Split decision: 10 FAIL · 3 NEUTRAL · 3 PASS

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (1/9)✗LynchFAIL (1/7)•GreenblattNot ranked•PiotroskiNEUTRAL (F-Score 6)✗DremanFAIL (3/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (0/6)✗MarksFAIL (2/5)✓AckmanPASS (5/9)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)✗AsnessFAIL (Rank #1873/2370 (Top 79.0%))✗NeffFAIL (2/6)✗SchlossFAIL (3/7)✗OshaughnessyFAIL (Rank #127/963 (Top 13.2%))
  • Debt & Leverage25% pass✓ 4✗ 11▾

    9 of 12 flag CLVT's debt & leverage — Graham, Buffett, Lynch +6 more

    Total Debt / Shareholders' Equity0.92
    ✗Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 0.91, IC: 0.3x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0.92
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities0.88
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Debt Levels0.92
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=0.3x, D/EBITDA=5.3x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0.92
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.9167; #3121/4210 (top 74.1%)
    ✗AsnessTop 30% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Business Services
Size: Small Cap($1.5B)
Revenue: $2.5B-4.0% YoY
Net Income: $201.1M+68.4% YoY

Financial Snapshot

Operating Margin2.9%
Return on Equity-4.2%
Debt / Equity0.91
Current Ratio0.84
EPS (Diluted)$-0.30
Buybacks (1y)$224.5M
Buybacks (2y)$424.5M
Shares Retired7.4% / 3.8% 2y

Similar Companies

ADPAUTOMATIC DATA PROCESSING INC
$122.3B
EAELECTRONIC ARTS INC.
$52.9B
RBRKRubrik, Inc.
$22.6B
ACMAECOM
$9.1B

Shareholder Return

Fiscal 2025

Retired 7.4% of shares last year, 3.8% over two.

Buybacks
$224.5M
Dividends
$0

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, operating cash flow, depreciation amortization, capex, dividends paid, buybacks.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, buybacks.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, buybacks.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-02-24
FY 2024
Sources
  • 10-K · 2025-02-19
FY 2023
Sources
  • 10-K · 2024-02-27
FY 2022
Sources
  • 10-K · 2023-03-01
FY 2021
Sources
  • 10-K · 2022-03-10
Market Cap$1.5Bcurrent------$1.7Best.$3.7Best.$6.0Best.$7.5Best.$11.2Best.
Revenue$2.3B↓9%$481.6M↓23%$587.3M↓5%$585.5M↓1%$2.5B↓4%$2.6B↓3%$2.6B↓1%$2.7B↑42%$1.9B
Operating Income-$88.5M↓175%$40.1M↓9%-$200.2M↓3001%$30.2M↑245%$71.5M↑126%-$275.6M↑62%-$734.7M↑81%-$3.9B↓4412%-$87.0M
Net Income-$386.5M↑2%-$80.8M↓186%-$268.6M↓273%-$40.2M↑61%-$201.1M↑68%-$636.7M↑30%-$911.2M↑77%-$4.0B↓1364%-$270.5M
EPS (Diluted)--$-0.13↓225%$-0.42↓282%$-0.06↑60%$-0.30↑69%$-0.96↑35%$-1.47↑76%$-6.24↓923%$-0.61
Gross Margin————66.0%66.0%↑1%65.5%↑2%64.1%↓4%66.6%
Operating Margin-3.9%↓203%8.3%↑18%-34.1%↓3170%5.2%↑247%2.9%↑127%-10.8%↑61%-27.9%↑81%-147.6%↓3084%-4.6%
ROE-8.6%↓6%———-4.2%↑66%-12.4%↑19%-15.2%↑74%-58.1%↓2463%-2.3%
Total Debt$4.1B↓6%$4.1B↓6%$4.2B↓7%$4.3B↓5%$4.4B↓2%$4.5B↓4%$4.7B↓6%$5.0B↓9%$5.5B
Shareholders' Equity$4.5B↓8%$4.5B↓8%$4.5B↓9%$4.8B↓5%$4.8B↓6%$5.1B↓14%$6.0B↓12%$6.8B↓43%$11.9B
Current Ratio0.88↑1%0.88↑1%0.85↓7%0.84↓4%0.84↓4%0.87↓5%0.91↑2%0.89↑4%0.86
Debt / Equity0.92↑2%0.92↑2%0.93↑3%0.89↓1%0.91↑4%0.88↑12%0.79↑7%0.73↑60%0.46
Operating Cash Flow$558.9M↓8%$165.6M↓9%$98.7M↓15%$134.7M↓21%$628.5M↓3%$646.6M↓13%$744.2M↑46%$509.3M↑57%$323.8M
Free Cash Flow$322.3M↓4%$110.2M↓5%$44.0M↓13%$78.9M↓28%$365.3M↑2%$357.5M↓29%$501.7M↑64%$306.4M↑49%$205.3M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Business Services

CLVT vs Peers — Financial Grading

Revenue$2.5BMedian
Net Income$201.1MBottom 25%
ROE-4.2%Bottom 25%
D/E0.91Median
Op. Margin2.9%Median
Curr. Ratio0.84Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
AUTOMATIC DATA PROCESSING INCADP$122.3B$309.93$21.9B$4.4B73.2%0.8224.2%1.054/95/93/70/3F-Score 65/11
ELECTRONIC ARTS INC.EA$52.9B$209.70$7.5B$887.0M13.1%0.2215.4%1.051/94/94/70/3F-Score 66/11
Rubrik, Inc.RBRK$22.6B$109.88$1.3B$348.8M67.1%—-26.2%1.691/90/92/70/3F-Score 62/11
AECOMACM$9.1B$70.50$16.1B$561.8M22.5%1.096.4%1.141/93/93/71/3F-Score 82/11
COMMVAULT SYSTEMS INCCVLT$6.2B$152.07$1.2B$70.7M942.8%—6.3%1.951/92/94/70/3F-Score 66/11
WPP plcWPP$6.0B$27.79$18.2B$289.5M-8.5%1.942.8%0.891/92/91/70/3F-Score 32/11
VARONIS SYSTEMS INCVRNS$5.6B$48.94$623.5M$129.3M-21.6%0.76-23.5%1.971/90/91/70/3F-Score 51/11
ROBERT HALF INC.RHI$4.3B$42.00$5.4B$133.0M10.4%—1.4%1.532/95/91/70/3F-Score 52/11